Global Asthma Drug Market 2022-2028

Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children. Asthma is caused by swelling (inflammation) of the breathing tubes that carry air in and out of the lungs. This makes the tubes highly sensitive, so they temporarily narrow. The global asthma drug market is likely to register a CAGR of over 4.2% with an incremental growth of USD 7 billion during the forecast period 2022-2028. The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global asthma drug market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the asthma drug industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the medication, route of administration, distribution channel, and region. The global market for asthma drug can be segmented by medication: quick-relief medications, long-term control medications. Asthma drug market is further segmented by route of administration: inhaled, prefilled syringe/vials, others. Based on distribution channel, the asthma drug market is segmented into: online pharmacies, hospitals, retail pharmacies. On the basis of region, the asthma drug market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). By medication: - quick-relief medications - long-term control medications By route of administration: - inhaled - prefilled syringe/vials - others

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

By distribution channel: - online pharmacies - hospitals - retail pharmacies By region: - Asia Pacific - Europe - North America - Rest of the World (RoW) The market research report covers the analysis of key stake holders of the global asthma drug market. Some of the leading players profiled in the report include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., Novartis International AG, Pfizer Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., among others. *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Historical & Forecast Period This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year. Scope of the Report - To analyze and forecast the market size of the global asthma drug market. - To classify and forecast the global asthma drug market based on medication, route of administration, distribution channel, region. - To identify drivers and challenges for the global asthma drug market. - To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global asthma drug market. - To identify and analyze the profile of leading players operating in the global asthma drug market. Why Choose This Report - Gain a reliable outlook of the global asthma drug market forecasts from 2022 to 2028 across scenarios. - Identify growth segments for investment. - Stay ahead of competitors through company profiles and market data. - The market estimate for ease of analysis across scenarios in Excel format. - Strategy consulting and research support for three months. - Print authentication provided for the single-user license.